About Kevin Lalande
Kevin Lalande is a director at Sensorium Therapeutics.
Kevin Lalande first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Lalande in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Lalande works with at each company, as listed on that company's latest Form D.
Sensorium Therapeutics, Inc. · Form D/A, Jul 15, 2025
JR
Jerrold Rosenbaum
Director
RK
Ryan Katz
Director
RS
Richard Simon
Director
BG
Balkrishan Gill
Director
AG
Alexandra Glucksmann
Director
JH
Jacob Hooker
Executive officer and director